Evaluating Elevance Health: Insights From 15 Financial Analysts
Portfolio Pulse from Benzinga Insights
Elevance Health (NYSE:ELV) has been analyzed by 15 financial analysts, showing a range of bullish to somewhat bullish sentiments. The average 12-month price target has increased by 3.2% to $612.93. Recent analyst actions include several rating raises and maintained overweight ratings, indicating positive sentiment towards the stock.
July 15, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elevance Health has received predominantly bullish ratings from analysts, with an average 12-month price target increase to $612.93. Recent actions include multiple rating raises and maintained overweight ratings, reflecting positive sentiment.
The majority of analysts have given bullish or somewhat bullish ratings, with no bearish ratings. The average price target has increased, and several analysts have raised their ratings or maintained overweight ratings, indicating strong positive sentiment towards Elevance Health.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100